Symbol: CXG.A-TSX Venture
Shares Outstanding: 18,714,810
MONTREAL, Sept. 21 /CNW Telbec/ - Mrs. Lisanne Dostie Chair of the Board
of Clemex Technologies Inc. (TSX Venture: CXG.a) announces today that
Erik Grandjean has been appointed Director on the Board of the Company.
Mr. Grandjean's nomination is effective immediately.
Mrs. Dostie declared: "We are very pleased to welcome Mr. Grandjean to
our Board of Directors. Mr. Grandjean has a wide experience in large and small
business financial affairs. He has seated on a Board of large Corporation as a
Director for nearly 20 years and has acted as high level management in several
large and mid-size companies. His expertise will complement perfectly other
Board members experience and competencies." Mrs. Dostie added: "We welcome
Mr. Grandjean amongst our team"
Since 2003, Mr. Grandjean is owner and President of Compumedia Design
(CMD), a company who designs and markets various technology signage systems.
Prior to this, he has acted as Executive Vice President for a venture capital
organization (Soquia) and has been partner and general manager of a strategic
planning consultant firm (SECOR). He has seated on several Boards amongst
which as a Director on the Board of an important Food manufacturing company
(Aliments Carrière). Mr. Grandjean graduated in Business and administration at
Université Laval, has a Master in Economics, a License in Political sciences,
and a License in Economics from Université de Genève.
Mr. Grandjean was granted 10,000 stock options at September 19th, 2007
closing price immediately at his nomination.
About Clemex Technologies, Inc.
Clemex Technologies Inc. develops, manufactures and markets image
analysis systems and software used by quality control and research microscopy
laboratories. Clemex customer base spans over many countries in America,
Europe, Asia and encompasses major Research and Development Centers,
prestigious Universities and large manufacturing industries in various fields
including automotive, aerospace, raw materials manufacturing, pharmaceuticals,
mining and other sectors.
The CDNX has not reviewed and does not accept responsibility for the
adequacy and accuracy of this news release.
For further information:
For further information: Clément Forget, (450) 651-6573, email@example.com